🔗 Share this article

As the US proceeds with historic revisions to its vaccine guidelines, a particular individual has emerged somewhat surprisingly: Høeg, a Danish American sports medicine doctor and epidemiologist who rose to prominence by casting doubt on Covid shots throughout the global health crisis and has concentrated on alleged deaths following COVID-19 vaccination in her short tenure at the US Food and Drug Administration (FDA).

Planned Shifts to Pediatric Vaccine Schedule

Public health authorities had intended to announce radical revisions to the pediatric vaccine schedule recently, bringing the US with the Danish vaccine program, according to reports – a major change that would place the US at odds with much of the global community with no evidence for public health gain. The announcement has been pushed back until the coming year.

Rather than the director of the vaccine center, Dr. Høeg is scheduled to address the audience at the meeting. She was recently named temporary leader of the FDA’s drug evaluation center, the fifth appointee to lead the division this year.

A New Direction at the Agency

This interim role might represent a tighter collaboration between the pharmaceutical and biologics centers as Høeg and Dr. Prasad strengthen their influence at the FDA – and it suggests a increased emphasis upon rolling back long-standing immunizations at the FDA.

Høeg has repeatedly called for discontinuing some pediatric shot schedules in the US in order to be more in line with Denmark's approach, a country with nationalized medicine and a number of inhabitants about the size of the state of Wisconsin.

So far comments, she has continued to focus on vaccines – traditionally the purview of Prasad, chief of the FDA’s vaccine center – instead of medication approval.

Doubts Over Expertise

Høeg has little discernible background in pharmaceutical research, regulation or administrative roles, which has been typical for former directors of the biologics center. She has served at the FDA as a top consultant to the FDA chief and the vaccine center since March.

“She appears not to have any of the qualifications” for leading the CDER, said Jonathan Howard. “She has not conducted a randomized controlled trial. She is not versed in managing a major agency. She lacks background in industry regulation.”

Former directors of the center would “grasp legal statutes and the science of medication creation”, commented Dr. Janet Woodcock. “Frankly, she lacks the type of experience that prior appointees who headed the center have had.”

This division has an immense range of responsibilities at the FDA, she stated.

“Everybody just zeroes in on the new drug program, but the generic drug division clears thousands of generic drugs. There’s a biologic copycat branch, non-prescription drug unit and more, and every single one have to be supervised,” Woodcock noted. “The area you neglect, that is precisely what that I always told people is going to cause problems.”

Furthermore, a substantial leadership element to the role, which supervises over 5,000 employees. “It’s a enormous administrative position, if you perform it correctly,” Woodcock added.

Official Statement and Contentious Initiatives

In response to questions about Høeg’s credentials and whether this appointment indicates increased cooperation among regulatory chiefs on immunizations, a press secretary said that the “questions stem from inaccurate assumptions”.

“Her resume is consistent with the duties of her role,” the representative said, citing the time Høeg spent advising the agency head on “drug safety and oversight research, including computerized risk analysis and vaccine surveillance”.

In her interim role, Dr. Høeg inherits the agency head's controversial fast-track approval initiative, a disputed one-day medication authorization process that reportedly concerned her preceding directors. “By what process are these medications being chosen for this fast-track system? Who is making the decisions?” Howard said. “There’s a lot of secrecy going on at the FDA right now.”

Overall, he remarked, “the FDA looks to be trending towards more relaxed regulations of all drugs, with the exception of vaccines.”

Public History on Immunizations

Regarding vaccines, Høeg has a more documented, if troubling, history, some experts have noted. She published a study using non-validated volunteer-provided data to assess the incidence of myocarditis after Covid vaccination. She consulted for the Florida top health official Dr. Joseph Ladapo, who reportedly have modified findings to indicate Covid vaccines are riskier than they are.

Part of her “wish list” for the current federal leadership included altering guidelines for recently developed shots and discontinuing “non-essential” vaccines, she said after the election on a audio program. At the agency, Dr. Høeg has according to sources suggested excluding adolescent males from obtaining COVID-19 vaccines.

“She is an all-around ideologue who starts off with her preconceived notions and reverse-engineers to accommodate the evidence in a extremely deceptive, fraudulent fashion,” Howard stated.

Gaining Influence and a “Revenge Tour”

Dr. Høeg became part of fellow skeptics, {like|